Signals, Powered By EquityPandit
On Thursday, Ajanta Pharma has launched eletriptan hydrobromide tablets which is used in treating headaches in the US market.
Ajanta Pharma has said in a BSE filing that “It is a bioequivalent generic version of Relpax tablets. Ajanta Pharma has launched the product in two strengths, 20 mg and 40 mg tablets.”
According to the company Eletriptan hydrobromide tablets is a part of its growing portfolio of products developed for the US market.
